Oral surgery, oral medicine, oral pathology and oral radiology · 2017
Differential expression of STAT-3 in subtypes of oral lichen planus: a preliminary study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Du Guanhuan, Chen Junjun, Wang Yanni, Cao Tianyi, Zhou Leilei, Wang Yufeng, Han Xiaozhe, Tang Guoyao
Аннотация
OBJECTIVE: This study aimed to examine the expression of signaling transduction proteins and their possible correlation with different clinical subtypes of oral lichen planus (OLP).
STUDY DESIGN: We examined the immunoexpression and phosphorylation status of 21 signaling transduction proteins of OLP (n = 10) and normal groups (n = 8) using PathScan analysis. Using immunohistochemistry, we detected expression of STAT-3 and p38 MAPK in tissues of OLP (n = 40) and normal controls (n = 10).
RESULTS: PathScan analysis showed that STAT-3 (Ser727) expression in normal control (N), reticular OLP (R-OLP) and erosive OLP (E-OLP) group was gradually elevated (R-OLP vs N, P = .001; E-OLP vs N, P < .001; E-OLP vs R-OLP, P = .002). Immunohistochemistry showed that STAT-3 expression in the epithelium of normal control, reticular OLP and erosive OLP was consistent with PathScan analysis (R-OLP vs N, P < .001; E-OLP vs N, P < .001; E-OLP vs R-OLP, P = .036). Both PathScan (P = .012) and immunohistochemistry (P < .001) showed that, p38 MAPK expression was significantly higher in OLP compared with normal controls. However, a significant difference was not seen between the reticular OLP and erosive OLP groups.
CONCLUSIONS: Our results indicate that STAT-3 may be involved in OLP development and progression and account for different clinical manifestations.
STUDY DESIGN: We examined the immunoexpression and phosphorylation status of 21 signaling transduction proteins of OLP (n = 10) and normal groups (n = 8) using PathScan analysis. Using immunohistochemistry, we detected expression of STAT-3 and p38 MAPK in tissues of OLP (n = 40) and normal controls (n = 10).
RESULTS: PathScan analysis showed that STAT-3 (Ser727) expression in normal control (N), reticular OLP (R-OLP) and erosive OLP (E-OLP) group was gradually elevated (R-OLP vs N, P = .001; E-OLP vs N, P < .001; E-OLP vs R-OLP, P = .002). Immunohistochemistry showed that STAT-3 expression in the epithelium of normal control, reticular OLP and erosive OLP was consistent with PathScan analysis (R-OLP vs N, P < .001; E-OLP vs N, P < .001; E-OLP vs R-OLP, P = .036). Both PathScan (P = .012) and immunohistochemistry (P < .001) showed that, p38 MAPK expression was significantly higher in OLP compared with normal controls. However, a significant difference was not seen between the reticular OLP and erosive OLP groups.
CONCLUSIONS: Our results indicate that STAT-3 may be involved in OLP development and progression and account for different clinical manifestations.